Thu 26 Nov 2009 | 9:05 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Synta Pharmaceuticals Corp.

Synta Pharmaceuticals Corp. (SNTA.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty ยท View SNTA on other exchanges
As of  25 Nov 2009
4.39USD
Price Change
+0.25
Percent Change
+6.04%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Rieder, Wendy 41 2006 Vice President - Intellectual Property and Legal Affairs, General Counsel
Vukovic, Vojo -- 2009 Senior Vice President, Chief Medical Officer
Chadwick, Jeremy 46 2006 Senior Vice President - Program Management and Clinical Operations
Koya, Keizo 51 2002 Senior Vice President - Drug Development
Bailey, Michael 43 2008 Senior Vice President - Business Development, Chief Commercial Officer
Bahcall, Safi 40 2003 President, Chief Executive Officer, Director
Chen, Lan Bo 65 2001 Director
Kovner, Bruce 64 2002 Director
Reardon, William 62 2004 Director
Wilson, Robert 68 2003 Director
Ehrlich, Keith 58 2006 Chief Financial Officer, Vice President - Finance and Administration
Gollust, Keith 63 2002 Chairman of the Board